SCHEMBL7701706

SCHEMBL7701706

CCOC(=O)/C=C/CC(C)(C)CCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
HCAR2 Q8TDS4 1/20 0.44
ALDH1A1 P00352 1/20 0.41
TTR P02766 1/20 0.40
DPP4 P27487 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP4F2 P78329 2/20 0.38
CYP4A11 Q02928 2/20 0.38
NPSR1 Q6W5P4 1/20 0.35
MAOB P27338 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.32
ESR1 P03372 1/20 0.32
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701708 1.00 MAPT (0.45) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL8459343 0.80 HCAR2 (0.52) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL8459344 0.80 HCAR2 (0.52) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL7698913 0.77 MAPT (0.38) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL7698911 0.77 MAPT (0.38) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL22734091 0.77 MAPT (0.49) MAPTHCAR2ALDH1A1TTRDPP4
Hydrochloric Acid SCHEMBL29911009 0.75 MAPT (0.47) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL5643847 0.74 MAPT (0.50) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL8152585 0.74 MAPT (0.50) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL12737213 0.74 MAPT (0.63) MAPTHCAR2ALDH1A1TTRDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed
EP-1056716-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 EP disclosed
WO-1999043646-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed